CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 259 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,438,139 | -39.2% | 123,023 | -30.1% | 0.00% | -100.0% |
| Q2 2023 | $2,364,620 | +5.5% | 175,939 | +30.2% | 0.00% | 0.0% |
| Q1 2023 | $2,240,854 | +82.2% | 135,154 | +104.5% | 0.00% | – |
| Q4 2022 | $1,229,571 | +92.1% | 66,106 | +32.6% | 0.00% | – |
| Q3 2022 | $640,000 | +580.9% | 49,835 | +271.2% | 0.00% | – |
| Q2 2022 | $94,000 | -96.8% | 13,424 | -96.2% | 0.00% | -100.0% |
| Q1 2022 | $2,935,000 | +4.9% | 354,024 | -14.3% | 0.00% | 0.0% |
| Q4 2021 | $2,797,000 | -30.5% | 413,088 | -45.6% | 0.00% | 0.0% |
| Q3 2021 | $4,025,000 | -10.4% | 759,658 | -2.7% | 0.00% | 0.0% |
| Q2 2021 | $4,491,000 | +699.1% | 781,091 | +540.1% | 0.00% | – |
| Q1 2021 | $562,000 | -28.9% | 122,019 | -48.4% | 0.00% | – |
| Q4 2020 | $790,000 | -12.4% | 236,410 | -22.2% | 0.00% | – |
| Q3 2020 | $902,000 | -25.1% | 303,682 | +16.4% | 0.00% | – |
| Q2 2020 | $1,205,000 | +38.7% | 260,851 | +15.5% | 0.00% | – |
| Q1 2020 | $869,000 | -53.6% | 225,767 | -54.7% | 0.00% | -100.0% |
| Q4 2019 | $1,871,000 | -21.3% | 498,845 | +11.5% | 0.00% | 0.0% |
| Q3 2019 | $2,376,000 | +425.7% | 447,286 | +280.0% | 0.00% | – |
| Q2 2019 | $452,000 | +33.7% | 117,692 | +77.9% | 0.00% | – |
| Q1 2019 | $338,000 | +111.2% | 66,160 | -20.7% | 0.00% | – |
| Q4 2018 | $160,000 | -1.8% | 83,463 | +94.0% | 0.00% | – |
| Q3 2018 | $163,000 | +30.4% | 43,020 | +7.2% | 0.00% | – |
| Q2 2018 | $125,000 | +22.5% | 40,115 | -5.8% | 0.00% | – |
| Q1 2018 | $102,000 | -33.8% | 42,601 | +8.1% | 0.00% | – |
| Q4 2017 | $154,000 | +108.1% | 39,415 | +35.3% | 0.00% | – |
| Q3 2017 | $74,000 | +146.7% | 29,128 | +11.8% | 0.00% | – |
| Q1 2016 | $30,000 | -43.4% | 26,056 | +21.4% | 0.00% | – |
| Q4 2015 | $53,000 | -18.5% | 21,465 | -0.6% | 0.00% | – |
| Q3 2015 | $65,000 | +306.2% | 21,585 | +472.4% | 0.00% | – |
| Q2 2015 | $16,000 | -95.1% | 3,771 | -95.0% | 0.00% | – |
| Q1 2015 | $328,000 | +21.5% | 75,750 | -16.8% | 0.00% | – |
| Q4 2014 | $270,000 | – | 91,075 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |